Loading clinical trials...
Loading clinical trials...
A Phase 3b, Randomized, Double-Blind, Placebo-Control, Multicenter, Evaluation of the Safety and Efficacy of N1539 Administered Preoperatively in Open Unilateral Total Knee Arthroplasty
Conditions
Interventions
N1539
Placebo
Locations
6
United States
Research Center
Florence, Alabama, United States
Research Center
Mobile, Alabama, United States
Research Center
Sheffield, Alabama, United States
Research Center
Tempe, Arizona, United States
Research Center
Tamarac, Florida, United States
Research Center
Vero Beach, Florida, United States
Start Date
February 19, 2018
Primary Completion Date
May 21, 2019
Completion Date
May 21, 2019
Last Updated
May 25, 2023
NCT04577690
NCT07360392
NCT05722002
NCT07512141
NCT06757075
NCT06528288
Lead Sponsor
Baudax Bio
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions